| Pharmaceutical Information |
| Drug Name |
Ethchlorvynol |
| Drug ID |
BADD_D02620 |
| Description |
Ethchlorvynol is a sedative and hypnotic drug. It has been used to treat insomnia, but has been largely superseded and is only offered where an intolerance or allergy to other drugs exists. |
| Indications and Usage |
Used for short-term hypnotic therapy in the management of insomnia for periods of up to one week in duration; however, this medication generally has been replaced by other sedative-hypnotic agents. |
| Marketing Status |
approved; illicit; withdrawn |
| ATC Code |
N05CM08 |
| DrugBank ID |
DB00189
|
| KEGG ID |
D00704
|
| MeSH ID |
D004984
|
| PubChem ID |
5281077
|
| TTD Drug ID |
D03VZH
|
| NDC Product Code |
Not Available |
| UNII |
6EIM3851UZ
|
| Synonyms |
Ethchlorvynol | Ethchlorvinol | Ethchlorovynol | Placidyl |
|
| Chemical Information |
| Molecular Formula |
C7H9ClO |
| CAS Registry Number |
113-18-8 |
| SMILES |
CCC(C=CCl)(C#C)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
